Substance-Related Disorders
Welcome,         Profile    Billing    Logout  
 67 Companies   95 Products   95 Products   124 Mechanisms of Action   1 Trial   1960 News 


«12...1314151617181920212223...3940»
  • ||||||||||  Enrollment open, Trial initiation date:  An Exercise App to Reduce Young Adults' MJ Use (clinicaltrials.gov) -  Nov 28, 2014   
    P=N/A,  N=52, Recruiting, 
    Recruiting --> Completed | N=150 --> 88 Not yet recruiting --> Recruiting | Initiation date: May 2013 --> Oct 2014
  • ||||||||||  Trial completion, Enrollment change:  MATRIS: Malm (clinicaltrials.gov) -  Nov 25, 2014   
    P=N/A,  N=79, Completed, 
    Recruiting --> Active, not recruiting | Trial primary completion date: May 2015 --> Dec 2015 Recruiting --> Completed | N=130 --> 79
  • ||||||||||  baclofen / Generic mfg.
    Enrollment closed:  Baclofen Effects on Marijuana Dependence (clinicaltrials.gov) -  Nov 20, 2014   
    P2,  N=77, Active, not recruiting, 
    Initiation date: Mar 2015 --> Mar 2014 Recruiting --> Active, not recruiting
  • ||||||||||  Enrollment change, Trial termination:  Electronic Cigarettes or Nicotine Inhaler for Smoking Cessation (clinicaltrials.gov) -  Nov 18, 2014   
    P=N/A,  N=3, Terminated, 
    N=40 --> 3 | Recruiting --> Terminated; No participants enrolled. Changed requirements for studying e-cigarettes.
  • ||||||||||  metadoxine / Generic mfg.
    Trial completion:  Metadoxine as a Therapy for Severe Alcoholic Hepatitis (clinicaltrials.gov) -  Nov 12, 2014   
    P4,  N=135, Completed, 
    Changed requirements for studying e-cigarettes. Active, not recruiting --> Completed
  • ||||||||||  Phase classification:  Gabapentin Treatment of Alcohol Dependence (clinicaltrials.gov) -  Nov 10, 2014   
    P2,  N=150, Completed, 
    Recruiting --> Completed Phase classification: P1/2 --> P2
  • ||||||||||  Enrollment closed, Trial primary completion date:  Lifestyle Intervention for Diabetes and Weight Management in Psychosis (clinicaltrials.gov) -  Nov 7, 2014   
    P=N/A,  N=120, Active, not recruiting, 
    Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2015 --> Dec 2015
  • ||||||||||  Viibryd (vilazodone) / AbbVie
    Enrollment closed:  Vilazodone Treatment for Marijuana Dependence (clinicaltrials.gov) -  Nov 7, 2014   
    P2,  N=76, Active, not recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2015 --> Dec 2015 Recruiting --> Active, not recruiting
  • ||||||||||  GET 73 / CT Pharmaceutical Laboratory
    Enrollment open, Trial initiation date, Trial primary completion date:  SPAD: Safety and Pharmacodynamic Study of GET 73 in Alcohol Dependent (clinicaltrials.gov) -  Nov 6, 2014   
    P1/2,  N=25, Recruiting, 
    Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting | Initiation date: Nov 2013 --> Oct 2014 | Trial primary completion date: Sep 2014 --> Nov 2015
  • ||||||||||  naltrexone / Generic mfg.
    Trial completion, Trial primary completion date:  Optimizing Pharmacotherapy for Bipolar Alcoholics (clinicaltrials.gov) -  Nov 5, 2014   
    P1/2,  N=88, Completed, 
    Not yet recruiting --> Recruiting Recruiting --> Completed | Trial primary completion date: Aug 2013 --> Apr 2013
  • ||||||||||  Trial completion:  PTSC: Persistence-Targeted Smoking Cessation (clinicaltrials.gov) -  Nov 4, 2014   
    P1,  N=58, Completed, 
    Recruiting --> Active, not recruiting Recruiting --> Completed
  • ||||||||||  Trial termination:  Relapse Prevention Study in Newly Abstinent Smokers (clinicaltrials.gov) -  Oct 30, 2014   
    P2,  N=425, Terminated, 
    Recruiting --> Completed Withdrawn --> Terminated; Study halted prior to enrollment of patients
  • ||||||||||  New P1 trial:  Clinical Trial Tobacco Marijuana (clinicaltrials.gov) -  Oct 30, 2014   
    P1,  N=90, Not yet recruiting, 
  • ||||||||||  methamphetamine / Generic mfg.
    Trial completion:  STAR: Study Targeting Affect Regulation (clinicaltrials.gov) -  Oct 27, 2014   
    P1/2,  N=56, Completed, 
    Withdrawn --> Terminated; Study halted prior to enrollment of patients Active, not recruiting --> Completed
  • ||||||||||  Trial primary completion date, Compliance:  MAPIT: Motivational Assessment Program to Initiate Treatment (clinicaltrials.gov) -  Oct 22, 2014   
    P=N/A,  N=600, Recruiting, 
    Recruiting --> Completed | Trial primary completion date: May 2014 --> Dec 2013 Trial primary completion date: Aug 2014 --> Feb 2015
  • ||||||||||  Trial initiation date:  Safety and Health Intervention Project (clinicaltrials.gov) -  Oct 22, 2014   
    P=N/A,  N=400, Not yet recruiting, 
    Trial primary completion date: Aug 2014 --> Feb 2015 Initiation date: Jul 2014 --> Oct 2014
  • ||||||||||  Trial completion:  Project SERVE: Post Deployment Functioning (clinicaltrials.gov) -  Oct 22, 2014   
    P=N/A,  N=309, Completed, 
    Initiation date: Jul 2014 --> Oct 2014 Active, not recruiting --> Completed
  • ||||||||||  citicoline / Generic mfg.
    Trial completion, Enrollment change, Trial initiation date, Trial primary completion date:  Effects of Citicoline on Brain Function and Behavior in Marijuana-Dependent Individuals (clinicaltrials.gov) -  Oct 22, 2014   
    P2,  N=21, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | N=36 --> 21 | Initiation date: Sep 2005 --> Sep 2009 | Trial primary completion date: Aug 2014 --> Jan 2013
  • ||||||||||  Trial completion:  Brief Intervention in Primary Care for Problem Drug Use and Abuse (clinicaltrials.gov) -  Oct 20, 2014   
    P=N/A,  N=868, Completed, 
    Recruiting --> Completed | N=36 --> 21 | Initiation date: Sep 2005 --> Sep 2009 | Trial primary completion date: Aug 2014 --> Jan 2013 Active, not recruiting --> Completed
  • ||||||||||  Trial completion, Trial primary completion date:  tRNS in Anterior Cingulate Cortex Reduces Craving Over Dual Pathology Patients (clinicaltrials.gov) -  Oct 17, 2014   
    P=N/A,  N=225, Completed, 
    Active, not recruiting --> Completed Not yet recruiting --> Completed | Trial primary completion date: Jan 2014 --> Aug 2014
  • ||||||||||  Cesamet (nabilone) / Bausch Health, Viatris
    Trial primary completion date:  Nabilone for Cannabis Dependence: A Pilot Study (clinicaltrials.gov) -  Oct 15, 2014   
    P2/3,  N=16, Active, not recruiting, 
    Trial primary completion date: Jun 2014 --> Jun 2015 Trial primary completion date: May 2013 --> Apr 2015
  • ||||||||||  Vivitrol (naltrexone extended-release injectable suspension) / Alkermes
    Trial completion, Trial primary completion date, Adverse events:  XRNT: Depot Naltrexone Mechanism of Action in Heroin Dependent Patients Using fMRI and SPECT (clinicaltrials.gov) -  Oct 15, 2014   
    P4,  N=40, Completed, 
    N=120 --> 150 | Trial primary completion date: Feb 2015 --> May 2016 Recruiting --> Completed | Trial primary completion date: Jan 2014 --> Oct 2014
  • ||||||||||  Enrollment open:  Transforming Opioid Prescribing in Primary Care (clinicaltrials.gov) -  Oct 11, 2014   
    P=N/A,  N=935, Recruiting, 
    Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
  • ||||||||||  Trial completion, Trial primary completion date:  ADAPT: Adolescent Substance Abuse: Progressive Treatment (clinicaltrials.gov) -  Oct 11, 2014   
    P1,  N=140, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Jun 2014 --> Aug 2013